ZA200004597B - Sustained-release preparation of physiologically active polypeptide and production thereof. - Google Patents

Sustained-release preparation of physiologically active polypeptide and production thereof.

Info

Publication number
ZA200004597B
ZA200004597B ZA200004597A ZA200004597A ZA200004597B ZA 200004597 B ZA200004597 B ZA 200004597B ZA 200004597 A ZA200004597 A ZA 200004597A ZA 200004597 A ZA200004597 A ZA 200004597A ZA 200004597 B ZA200004597 B ZA 200004597B
Authority
ZA
South Africa
Prior art keywords
sustained
release preparation
polypeptide
physiologically active
active polypeptide
Prior art date
Application number
ZA200004597A
Other languages
English (en)
Inventor
Yutaka Yamagata
Masafumi Misaki
Susumu Iwasa
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of ZA200004597B publication Critical patent/ZA200004597B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647Polyesters, e.g. poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/27Growth hormone [GH], i.e. somatotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
ZA200004597A 1998-03-20 2000-09-01 Sustained-release preparation of physiologically active polypeptide and production thereof. ZA200004597B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7185398 1998-03-20

Publications (1)

Publication Number Publication Date
ZA200004597B true ZA200004597B (en) 2002-02-27

Family

ID=13472521

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200004597A ZA200004597B (en) 1998-03-20 2000-09-01 Sustained-release preparation of physiologically active polypeptide and production thereof.

Country Status (12)

Country Link
US (1) US6482864B1 (xx)
EP (1) EP1061948B1 (xx)
KR (1) KR20010042079A (xx)
CN (1) CN1301172A (xx)
AT (1) ATE230274T1 (xx)
AU (1) AU744354B2 (xx)
BR (1) BR9908936A (xx)
CA (1) CA2324568A1 (xx)
DE (1) DE69904701T2 (xx)
DK (1) DK1061948T3 (xx)
WO (1) WO1999048519A1 (xx)
ZA (1) ZA200004597B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020063853A (ko) 1999-09-17 2002-08-05 다케다 야쿠힌 고교 가부시키가이샤 단백질 분체의 제조 방법
DE60136958D1 (de) 2000-12-01 2009-01-22 Takeda Pharmaceutical Verfahren zur herstellung einer zubereitung mit einer bioaktiven substanz
US8637077B2 (en) 2000-12-28 2014-01-28 Takeda Pharmaceutical Company Limited Sustained-release preparation
WO2002085399A1 (en) * 2001-04-20 2002-10-31 Takeda Chemical Industries, Ltd. Peptide-containing preparations
CN1310671C (zh) * 2001-07-09 2007-04-18 安斯泰来制药有限公司 缓释注射剂用组合物的制造方法
US7202326B2 (en) * 2002-09-24 2007-04-10 Asahi Kasei Chemicals Corporation Glycolic acid copolymer and method for production thereof
JP2007514752A (ja) * 2003-12-16 2007-06-07 ソシエテ・ドゥ・コンセイユ・ドゥ・ルシェルシュ・エ・ダプリカーション・シャンティフィック・エス・ア・エス Glp−1医薬組成物
US7464012B2 (en) * 2004-12-10 2008-12-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Simplified process simulator
US7582312B2 (en) * 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
US8236759B2 (en) * 2005-06-30 2012-08-07 Ipsen Pharma Sas GLP-1 pharmaceutical compositions
US20070004616A1 (en) * 2005-06-30 2007-01-04 Roland Cherif-Cheikh GLP-1 pharmaceutical compositions
CA2704111C (en) * 2007-05-14 2017-06-20 Sustained Nano Systems Llc Hypercompressed particles for controlled release of ophthalmic medications
US8071119B2 (en) 2007-05-14 2011-12-06 Sustained Nano Systems Llc Controlled release implantable dispensing device and method
JP2012524779A (ja) * 2009-04-23 2012-10-18 サステインド ナノ システムズ リミテッド ライアビリティ カンパニー 制御放出分配デバイス
CN102145160A (zh) * 2011-03-07 2011-08-10 深圳市健元医药科技有限公司 一种lhrh拮抗剂注射用的缓释植入制剂
CN102580056B (zh) * 2011-12-16 2014-04-09 深圳市健元医药科技有限公司 一种含抗利尿成分的缓释注射剂及其制备方法
CN113695370B (zh) * 2021-08-30 2022-06-07 河北科技大学 一种天然低共熔离子液体及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962091A (en) 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
DE69005800T2 (de) 1989-05-01 1994-05-19 Alkermes Inc Verfahren zur herstellung von kleinen partikeln von biologisch aktiven molekülen.
US5478564A (en) 1990-02-22 1995-12-26 Teva Pharmaceutical Industries, Ltd. Preparation of microparticles for controlled release of water-soluble substances
FR2658432B1 (fr) 1990-02-22 1994-07-01 Medgenix Group Sa Microspheres pour la liberation controlee des substances hydrosolubles et procede de preparation.
DE59309257D1 (de) 1992-10-26 1999-02-11 Sanol Arznei Schwarz Gmbh Verfahren zur herstellung von mikrokapseln
DE69329295T2 (de) 1992-12-02 2001-03-15 Alkermes Inc Wachstumhormon enthaltende mikrosphaeren mit kontrollierter freisetzung
US6087324A (en) * 1993-06-24 2000-07-11 Takeda Chemical Industries, Ltd. Sustained-release preparation
NZ260909A (en) 1993-07-05 1995-04-27 Takeda Chemical Industries Ltd Production of sustained release preparation by allowing a water-soluble polypeptide to permeate into a biodegradable matrix in an aqueous solution
ATE268591T1 (de) * 1995-06-27 2004-06-15 Takeda Chemical Industries Ltd Verfahren zur herstellung von zubereitungen mit verzögerter freisetzung
CA2241322C (en) 1996-03-28 2009-01-13 Takeda Chemical Industries, Ltd. Sustained-release preparation and its production
ATE233088T1 (de) 1996-12-20 2003-03-15 Takeda Chemical Industries Ltd Verfahren zur herstellung einer zusammensetzung mit verzoegerter abgabe
US6287587B2 (en) 1997-07-15 2001-09-11 Takeda Chemical Industries, Ltd. Process for producing sustained-release preparation by in-water drying

Also Published As

Publication number Publication date
EP1061948B1 (en) 2003-01-02
EP1061948A1 (en) 2000-12-27
DE69904701T2 (de) 2003-11-06
DE69904701D1 (de) 2003-02-06
DK1061948T3 (da) 2003-03-31
US6482864B1 (en) 2002-11-19
AU744354B2 (en) 2002-02-21
BR9908936A (pt) 2005-10-25
CA2324568A1 (en) 1999-09-30
KR20010042079A (ko) 2001-05-25
WO1999048519A1 (en) 1999-09-30
AU2853399A (en) 1999-10-18
CN1301172A (zh) 2001-06-27
ATE230274T1 (de) 2003-01-15

Similar Documents

Publication Publication Date Title
ZA200004597B (en) Sustained-release preparation of physiologically active polypeptide and production thereof.
IL124373A0 (en) Method of producing morphologically uniform microcapsules and microcapsules produced by this method
AU7871298A (en) Method of producing a sustained-release preparation
NO942515D0 (no) Fremgangsmåte for fremstilling av preparater for vedvarende frigiving
ES2054613T3 (es) Un metodo para preparar una formulacion de liberacion mantenida.
TR200002059T2 (tr) Devamlı salınan bileşim, üretim yöntemi ve kullanımı.
AU5490498A (en) Binder removal
DE60026982D1 (de) Verfahren zur bildung von feinem pulver
ATE149826T1 (de) Verfahren zur herstellung von festen pharmazeutischen retardformen
DE60030999D1 (de) Verfahren zur herstellung von teilchen
EP1258254A4 (en) COMPOSITIONS FOR DELAYED DELIVERY OF PHYSIOLOGICALLY ACTIVE COMPOUNDS THAT ARE LOW WATER-SOLUBLE, METHOD FOR THE PRODUCTION AND USE THEREOF
DE50007153D1 (de) 3d-matrix zur herstellung von zelltransplantaten
ATE287879T1 (de) Verfahren zur herstellung von isoflavonen
JPS645460A (en) Production of delaying gelatinous material
DE3770792D1 (de) Verfahren zur herstellung von rieselfaehigen, stabilen persaeure-konzentraten durch kompaktierende granulation.
NO20011031D0 (no) FremgangsmÕte for fremstilling av N-beskyttede azetidin-2- karboksylsyrer (AzeOHs)
ES8106309A1 (es) Un procedimiento para la preparacion de acido 9-o-metilcla- vulanico
JPS6414201A (en) Production of polyoxyethylenated chitin
JPS5227739A (en) Process for preparation of 3-substituted or non-substituted-4-hydroxyb enzaldehyde by electrolytic oxidation
ES2171466T3 (es) Recuperacion de indigo insoluble.
HU901875D0 (en) Process for production of galenical preparations providing optimal biological accessibility of 2-hydroxi-5-methyl-laurophenon-oxim as active substance
EP1081228A3 (en) Process for producing carboxylic acid isomer
MY137527A (en) Polymeric compounds and methods of formulating same
UA10180C2 (uk) Спосіб одержання біологічно активної речовини, що має регенераторну та модулюючу дію
UA36271A (uk) Спосіб отримання рідкого стимулятора росту і розвитку рослин з гумусомісткої речовини